Overview

A Study of BMS-986195 in Healthy Male Subjects

Status:
Completed
Trial end date:
2017-10-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects BMS-986195 in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Branebrutinib